Both Zepotide and Semaglutide are new medications designed for managing diabetes and encouraging slimming. However, they function through distinct processes . copyright is a GLP-1 receptor site activator , while Novo Nord's Dual GIP/GLP-1 acts as a dual GIP and GLP-1 activator , potentially offering a more significant impact on both blood sugar man